Oxidative Stress in the in vivo DMBA Rat Model of Breast Cancer: Suppression by a Voltage-gated Sodium Channel Inhibitor (RS100642)

Basic and Clinical Pharmacology and Toxicology

Volumn 111, Issue 2, 2012, Pages 137-141

  Batcioglu, Kadir ^a   Uyumlu, A Burcin ^a   Satilmis, Basri ^a   Yildirim, Battal ^a   Yucel, Neslihan ^a   Demirtas, Hakan ^b   Onkal, Rustem ^c,d   Guzel, R Mine ^c   Djamgoz, Mustafa B A ^c,d  

^a INONU UNIVERSITY   (Turkey)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d CYPRUS INTERNATIONAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRATE; RS 100642; SODIUM CHANNEL BLOCKING AGENT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER MODEL; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IN VIVO STUDY; LIFESPAN; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE PEROXIDASE; MALONDIALDEHYDE; MAMMARY NEOPLASMS, EXPERIMENTAL; MEXILETINE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SODIUM CHANNEL BLOCKERS; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 84864006656     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00880.x     Document Type: Article

References (52)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
3. Kumaraguruparan R, Balachandran C, Manohar BM, Nagini S. Altered oxidant-antioxidant profile in canine breast tumors. Vet Res Commun 2005;29:287-96.
4. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S, Becchetti A. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 2009;16:66-93.
5. Onkal R, Djamgoz MBA. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer. Eur J Pharmacol 2009;625:206-19.
6. Prevarskaya N, Skryma R, Shuba Y. Ion channels and the hallmarks of cancer. Trends Mol Med 2010;16:107-21.
7. Wolff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 2009;8:982-1001.
8. Hille B. Ion Channels of Excitable Membranes, 3rd edn. Sinauer, Sunderland, MA, 2001.
9. Diss JKJ, Fraser SP, Djamgoz MBA. Voltage-gated Na+ channels: multiplicity of expression, plasticity, functional implications and pathophysiological aspects. Eur Biophys J 2004;33:180-93.
10. Grimes JA, Fraser SP, Stephens GJ, Downing JEG, Laniado ME, Foster CS et al.Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Lett 1995;369:290-4.
11. Djamgoz MBA Bioelectricity of cancer: Voltage-gated ion channels and direct-current electric fields. In: Pullar C, (ed.). The Physiology of Bioelectricity in Development, Tissue Regeneration and Cancer. CRC Press, London and NY, 2011; 267-92.
12. Anderson JD, Hansen TP, Lenkowski PW, Walls AM, Choudhury IM, Schenck HA et al.Voltage-gated sodium channel blockers as cytostatic inhibitors of the androgen-independent prostate cancer cell line PC-3. Mol Cancer Ther 2003;2:1149-54.
13. Fiske JL, Fomin VP, Brown ML, Duncan RL, Sikes RA. Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev 2006;25:493-500.
14. House CD, Vaske CJ, Schwartz AM, Obias V, Frank B, Luu T et al.Voltage-gated sodium channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res 2010;70:6957-67.
15. Fraser SP, Diss JKJ, Chioni AM, Mycielska ME, Pan H, Yamaci RF et al.Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin Cancer Res 2005;11:5381-9.
16. Giri U, Sharma SD, Abdulla M, Athar M. Evidence that in situ generated reactive oxygen species act as a potent stage I tumor promoter in mouse skin. Biochem Biophys Res Commun 1995;209:698-705.
17. Henry L, Narendra PS. Oral artemisinin prevents and delays the development of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett 2006;231:43-4.
18. Salet C, Moreno G. Photosensitization of mitochondria. Molecular and cellular aspects. J Photochem Photobiol, B 1990;5:133-50.
19. Arulkumaran S, Ramprasath VR, Shanthi P, Sachdanandam P. Restorative effect of Kalpaamruthaa, an indigenous preparation, on oxidative damage in breast gland mitochondrial fraction in experimental mammary carcinoma. Mol Cell Biochem 2006;291:77-82.
20. Sheets MF, Fozzard HA, Lipkind GM, Hanck DA. Sodium channel molecular conformations and antiarrhythmic drug affinity. Trends Cardiovasc Med 2010;20:16-21.
21. Saarinen NM, Warri A, Airio M, Smeds A, Makela S. Role of dietary lignans in the reduction of breast cancer risk. Mol Nutr Food Res 2007;51:857-66.
22. Lowry OH, Roesbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
23. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein. J Biol Chem 1969;244:6049-55.
24. Luck H. Catalase. In: Bergmeyer HU (ed.). Methods in Enzymatic Analysis. Verlag-Chemie-Academic Press, Weinhelm-New York, 1963; 885-8.
25. Lawrence RA, Burk RF. GSH-Px activity in rat liver. Biochem Biophys Res Commun 1976;71:952-8.
26. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-8.
27. Sastry KVH, Moudgal RP, Mohan J, Tyagi JS, Rao GS. Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 2002;306:79-82.
28. Rieder CRM, Parsons RB, Fitch NJS, Williams AC. Human brain cytochrome P4501B1: immunohistochemical localization in human temporal lobe and induction by dimethylbenz(a)anthracene in astrocytoma cell line (MOG-G-CCM). Neurosci Lett 2000;278:177-80.
29. Cavalieri E, Roth R, Rogan E. Mechanisms of tumor initiation by polycyclic aromatic hydrocarbons. Carcinogenesis 1978;3:273-87.
30. Choi EJ. Antioxidative effects of hesperetin against 7, 12 dimethylbenz(a)anthracene-induced oxidative stress in mice. Life Sci 2008;82:1059-64.
31. Benakanakere I, Besch-Williford C, Carroll CE, Hyder SM. Synthetic progestins differentially promote or prevent 7, 12-DMBA-induced mammary tumors in Sprague-Dawley rats. Cancer Prev Res 2010;3:1157-67.
32. Vinothini G, Murugan RS, Nagini S. Evaluation of molecular markers in a rat model of mammary carcinogenesis. Oncol Res 2009;17:483-93.
33. Fang J, Seki T, Maeda H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv Drug Deliv Rev 2009;61:290-302.
34. Doroshow JH. Glutathione peroxidase and oxidative stress. Toxicol Lett 1995;83:395-8.
35. Moselhy SS, Al mslmani MAB. Chemopreventive effect of lycopene alone or with melatonin against the genesis of oxidative stress and mammary tumors induced by 7, 12 dimethyl(a)benzanthracene in sprague dawley female rats. Mol Cell Biochem 2008;319:175-80.
36. Selamoglu TZ, Yilmaz I, Ozdemir I, Ates B, Gok Y, Cetinkaya B. Role of synthesized organoselenium compounds on protection of rat erythrocytes from DMBA-induced oxidative stress. Biol Trace Elem Res 2009;128:167-75.
37. Williams EL, Djamgoz MBA. Nitric oxide and metastatic cell behaviour. BioEssays 2005;27:1228-38.
38. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumor progression. Nat Rev Cancer 2006;6:521-34.
39. Ridnour LA, Thomas DD, Switzer C, Flores-Santana W, Isenberg JS, Ambs S et al.Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide 2008;19:73-6.
40. Jenkins DC, Charles IG, Thomson LL, Moss DW, Holmes LS, Baylis SA et al.Role of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995;92:4392-6.
41. Mariyoma A, Tabaru A. Plasma nitrate concentrations as a tumor marker for hepatocellular carcinoma. Clin Chim Acta 2000;296:181-5.
42. Dale JR, Lin Y, Ved H, Koenig M, Clapp L, Hunter J et al.RS100642-198, a novel sodium channel blocker, provides differential neuroprotection against hypoxia/hypoglycemia, veratridine or glutamate-mediated neurotoxicity in primary cultures of rat cerebellar neurons. Neurotox Res 2001;3:381-95.
43. Williams AJ, Tortella FC. Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat. Brain Res 2002;932:45-55.
44. Laniado ME, Lalani EN, Fraser SP, Grimes JA, Bhangal G, Djamgoz MBA et al.Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am J Pathol 1997;150:1213-21.
45. Ekberg J, Craik DJ, Adams DJ. Conotoxin modulation of voltage-gated sodium channels. Int J Biochem Cell Biol 2008;40:2363-8.
46. Kapoor R. Sodium channel blockers and neuroprotection in multiple sclerosis using lamotrigine. J Neurol Sci 2008;274:54-6.
47. Haines BC, Waxman SG. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Invest Ophthalmol Vis Sci 2005;46:4164-9.
48. Marton Z, Halmosi R, Horvath B, Alexy T, Kesmarky G, Vekasi J et al.Scavenger effect of experimental and clinically used cardiovascular drugs. J Cardiovasc Pharmacol 2001;38:745-53.
49. + efflux in caveolae. Oncogene 2011;30:2070-6.
50. 2+ exchange is critical for vascular endothelial growth factor-mediated extracellular signal-regulated kinase (ERK) 1/2 activation and angiogenic functions of human endothelial cells. J Biol Chem 2011;286:37919-31.
51. Hidalgo C, Donoso P. Crosstalk between calcium and redox signaling: from molecular mechanisms to health implications. Antioxid Redox Signal 2008;10:1275-312.
52. Restrepo-Angulo I, De Vizcaya-Ruiz A, Camacho J. Ion channels in toxicology. J Appl Toxicol 2010;30:497-512.